Status:
UNKNOWN
Novel Quantitative Magnetic Resonance Imaging (MRI) Measures in the Assessment and Follow-up of Patients With Pulmonary Hypertension (PH)
Lead Sponsor:
Royal Brompton & Harefield NHS Foundation Trust
Conditions:
Pulmonary Hypertension
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
A prospective study of the use of two novel MRI techniques (oxygen-enhanced and fourier decomposition MRI) in the initial diagnosis and follow-up of patients with Pulmonary Hypertension. The investiga...
Eligibility Criteria
Inclusion
- Confirmed diagnosis of Pulmonary Hypertension.
- Age 18 and over.
Exclusion
- Standard contra-indications to MRI (as per NHS MRI safety questionnaire).
- Not medically fit for transfer to MRI.
- Patient judged inappropriate for involvement in study by clinical team e.g. secondary to emotional burden of recent diagnosis.
Key Trial Info
Start Date :
November 19 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04088279
Start Date
November 19 2018
End Date
June 1 2021
Last Update
September 12 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Brompton Hospital
London, United Kingdom